One North

 

 

One North is a 200 hectare development located in central Singapore. It plays host to 3 hubs to house key public and private institutes and organizations: Biopolis,  Fusionopolis, and Mediapolis. The new Star Vista mall is the latest addition and is the first major mall in Buona Vista area.

Biopolis provides world class research facilities for Biomedical Sciences. Scientists, technoprenuers and researchers can meet and form partnerships to establish renowned scientific institutions, through in-depth research and graduate training programmes. It also enables researchers to cut costs tremendously by having access state-of-the-art facilities, scientific infrastructure and specialised services.

Fusionopolis is the first integrated work-live-play-learn development in one-north. It supports the development of Infocomms Technology (ICT), Media, Physical Sciences and Engineering.

Mediapolis houses Singapore’s media ecosystem from incubation and R&D, to content production, distribution and playout. It is a digital media capital where top quality content will be produced for international markets

Vista Xchange is designated to be the premium business centre, residential and entertainment hub of One North. It houses Rochester Mall, Park Avenue Rochester Hotel, Star Vista mall and Metropolis, which will have two office towers and retail space.

Wessex Estate is home to Singapore’s creative community.

The One North development will be done in stages and completed in its entirety in approximately 15 years. The changes toward this area has tremendous investment potential given the area’s accessibility, presence of enterprises generating leasing demands, and ultimately capital appreciation.

 

 

One North Project For Rent

Project Price/psf (S$) Remarks
Infinite Studios @ Mediapolis 4.70 Media Usage
Nexus @ Fusionopolis 5.80 – 6.00 Business Park Usage
Solaris (Award winning Dev) 6.50 Business Park Usage
Synapse 5.95 Biomedical Usage
Nucleos @ Biopolis 4.95 Research unit
Neuros/Immunos 5.5 Biomedical Usage

 

 

Comments are closed.